Zucara Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 12

Employees
  • Latest Deal Type

  • Series A

  • Latest Deal Amount

  • $21M

  • Investors

  • 8

Zucara General Information

Description

Developer of a novel drug therapy designed to prevent hypoglycemia in people with diabetes. The company's drug therapy is delivered as a once-daily subcutaneous injection, which will benefit patients by addressing the significant morbidity and mortality associated with hypoglycemia, enabling healthcare providers to change diabetes disease management and improve both patient health and quality of life.

Contact Information

Website
www.zucara.ca
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1300-661 University Avenue
  • Toronto, Ontario M5G 0B7
  • Canada

Zucara Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zucara Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 31-Mar-2020 $21M 000.00 Completed Clinical Trials - Phase 1
7. Grant 12-Jul-2019 0000 00.000 Completed Pre-Clinical Trials
6. Debt - General 09-Apr-2018 00.00 00.000 Completed Pre-Clinical Trials
5. Accelerator/Incubator 09-Feb-2018 00000 Completed Pre-Clinical Trials
4. Grant 08-Feb-2018 00000 00000 Completed Pre-Clinical Trials
3. Grant 21-Sep-2017 00000 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 03-Nov-2016 Cancelled Startup
1. Early Stage VC 03-Nov-2016 $525K $525K Completed Startup
To view Zucara’s complete valuation and funding history, request access »

Zucara Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel drug therapy designed to prevent hypoglycemia in people with diabetes. The company's drug therapy i
Drug Discovery
Toronto, Canada
12 As of 2022
000.00
00000000000 000.00

000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000 000000000
San Diego, CA
000 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zucara Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 Formerly VC-backed San Diego, CA 000 00000 000000&0 00000
You’re viewing 1 of 1 competitors. Get the full list »

Zucara Executive Team (6)

Name Title Board Seat Contact Info
Michael Midmer Co-Founder, Chief Executive Officer & Board Member
Richard Liggins Ph.D Co-Founder & Chief Scientific Officer
Michael Riddell Ph.D Co-Founder & Chairman of Clinical Advisory Board
David Coy Ph.D Advisor
Mladen Vranic Ph.D Advisor
You’re viewing 5 of 6 executive team members. Get the full list »

Zucara Board Members (8)

Name Representing Role Since
Christopher Garabedian Self Board Member 000 0000
Claude Piché Self Board Member 000 0000
Frederick Callori JD Self Board Member 000 0000
Michael Martin Zucara Board Member 000 0000
Michael Midmer Zucara Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Zucara Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zucara Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Perceptive Advisors Hedge Fund Minority 000 0000 000000 0
Xontogeny Accelerator/Incubator Minority 000 0000 000000 0
GlycoNet Not-For-Profit Venture Capital 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority 000 0000 000000 0
National Research Council Canada Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial